Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02982174 · ClinicalTrials.gov registry record
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 15
- Enrollment target
NCT02982174: Completed study, sponsored by Topcon Medical Systems.
NCT02982174 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02982174 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Compare the signal to noise ratio of each device at various retinal layers.
Interventions
- DEVICE 3D OCT-1 Maestro
- DEVICE DRI OCT Triton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02982174
The ClinicalTrials.gov registry entry for NCT02982174 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 3D OCT-1 Maestro is the first listed.
NCT02982174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02982174 about?
NCT02982174 is a clinical study titled "Evaluation of the Signal to Noise Ratio at Various Retinal Layers". Compare the signal to noise ratio of each device at various retinal layers.
What is the current status of trial NCT02982174?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2016-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02982174?
The interventions under investigation include: 3D OCT-1 Maestro (DEVICE), DRI OCT Triton (DEVICE).
Who is sponsoring clinical trial NCT02982174?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.